Skip to content

Medical-device intelligence

Becton Dickinson & Co: FDA clearances and recalls

Research Becton Dickinson & Co in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

196 clearance records and 250 recall records in the covered releases, across 1 source company names and 77 product codes. Dated history runs from Apr 12, 13 to Aug 13, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202501
November 202500
December 202500
January 202600
February 202600
March 202600
April 202602
May 202600
June 202600
July 202600
August 202602
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

446 matching records
Device / recordCompany in FDA recordSourceSource date
BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635Z-1024-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621Z-1025-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733and 231274Z-1026-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657and 231658Z-1027-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678Z-1028-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219Z-1029-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175Z-1030-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and 231645Z-1031-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706Z-1032-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 and 231704Z-1033-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251Z-1034-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758Z-1035-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672Z-1036-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231691 and 2316…Z-1037-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544Z-1038-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 23…Z-1039-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344Z-1040-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023Z-0110-2024 · MDBBecton Dickinson & Co.RecallOct 12, 2023FDA classification date
BD Synapsys Informatics Solution, Catalog Number 444150Z-2099-2023 · JQPBecton Dickinson & Co.RecallJul 6, 2023FDA classification date
BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, 30 Single Use Test Devices- Intended for the in vitro, simultaneous qualitative de…Z-1682-2023 · QMNBecton Dickinson & Co.RecallJun 2, 2023FDA classification date
BD Kiestra InoqulA+ with BD Kiestra" InoqulA+" and BeA Software version 5.1 and 5.1.1 as part of the Icefall A platform. An in vitro diagnostic m…Z-1415-2023 · JTCBecton Dickinson & Co.RecallApr 20, 2023FDA classification date
BBL Chocolate II Agar- IVD for the isolation and cultivation of Neisseria species. Catalog (Ref) Number: 221267Z-0473-2023 · JTYBecton Dickinson & Co.RecallDec 9, 2022FDA classification date
BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the rapid identification and susceptibility of most aerobic and facultative anaero…Z-0232-2023 · LONBecton Dickinson & Co.RecallNov 14, 2022FDA classification date
BD Synapsys Microbiology Informatics Solution, Catalog Number 444150, Software Version 4.10Z-1018-2022 · JQPBecton Dickinson & Co.RecallApr 29, 2022FDA record creation date
BD Veritor Plus Analyzer - intended to provide rapid test results in near-patient settings. Catalog Number: 256066Z-0630-2022 · PSZBecton Dickinson & Co.RecallFeb 9, 2022FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗